Evidence map›Paper›PMID 41205000›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Should we consider gender aspects in pharmacology teaching? No-we must!

Jan Matthes

Abstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jan MatthesCentre of Pharmacology, Department II, and Medical Faculty, Student Dean's Office, University of Cologne and University Hospital Cologne, Cologne, Germany. jan.matthes@uni-koeln.de.ORCID http://orcid.org/0000-0003-2754-1555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gender aspects must be part of pharmacology teaching. Pharmacology offers a wealth of examples that prove on the one hand that sex and gender aspects of drug therapy are clinically relevant and on the other hand show that there are still striking omissions in pharmacological research and drug approval. And we should not forget that drug therapy is more than just applied pharmacology and includes, for example doctor-patient communication in the context of a prescription conversation. Moreover, it is not only that sex can make differences in pharmacodynamics and pharmacokinetics and thus in drug therapy-sex and gender can also play a role in (medical) education. Finally, gender-related discrimination continues to be a problem in our society and universities have set themselves the task of having an impact on society as the so-called "third mission". Pharmacology and drug therapy are excellent for working not only on this mission but also on creating awareness among future physicians of the importance of fair and appropriate consideration of sex and gender in medicine and society.

Indexed as

Education, MedicalPharmacologySexismFemaleHumansMaleSex FactorsGenderMedical educationPharmacology teaching

Identifiers

PMID41205000
PMCPMC13046624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.